Lance Wollenberg

1.5k total citations
23 papers, 316 citations indexed

About

Lance Wollenberg is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lance Wollenberg has authored 23 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Lance Wollenberg's work include Colorectal Cancer Treatments and Studies (9 papers), Melanoma and MAPK Pathways (9 papers) and Molecular Junctions and Nanostructures (3 papers). Lance Wollenberg is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Melanoma and MAPK Pathways (9 papers) and Molecular Junctions and Nanostructures (3 papers). Lance Wollenberg collaborates with scholars based in United States, France and Australia. Lance Wollenberg's co-authors include Loren Berry, Zhiyang Zhao, Peter M. Gannett, Timothy S. Tracy, Darcy R. Flora, David Lederman, Nianqiang Wu, Mingli Yang, Lin Xu and Murali Subramanian and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and The Journal of Physical Chemistry B.

In The Last Decade

Lance Wollenberg

22 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lance Wollenberg United States	10	135	78	53	39	32	23	316
Phuong Tu Huynh South Korea	14	139 1.0×	72 0.9×	93 1.8×	23 0.6×	42 1.3×	20	523
May Y. K. Ho United States	10	128 0.9×	105 1.3×	41 0.8×	28 0.7×	63 2.0×	17	338
Natalie M. G. M. Appels Netherlands	7	222 1.6×	103 1.3×	26 0.5×	63 1.6×	15 0.5×	11	396
Raquel F. Reinoso Spain	11	172 1.3×	98 1.3×	86 1.6×	56 1.4×	21 0.7×	27	540
Jia Ni China	15	146 1.1×	66 0.8×	48 0.9×	35 0.9×	65 2.0×	27	515
Wei Bao China	14	308 2.3×	102 1.3×	25 0.5×	21 0.5×	24 0.8×	36	529
M. J. van Maanen Netherlands	10	117 0.9×	140 1.8×	42 0.8×	34 0.9×	11 0.3×	14	358
Eslam Nouri-Nigjeh United States	13	165 1.2×	87 1.1×	45 0.8×	12 0.3×	71 2.2×	14	451
A. Yu. Misharin Russia	11	211 1.6×	31 0.4×	77 1.5×	21 0.5×	17 0.5×	57	439
Yasushi Fujioka Japan	14	106 0.8×	188 2.4×	50 0.9×	19 0.5×	28 0.9×	27	536

Countries citing papers authored by Lance Wollenberg

Since Specialization

Citations

This map shows the geographic impact of Lance Wollenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance Wollenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance Wollenberg more than expected).

Fields of papers citing papers by Lance Wollenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance Wollenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance Wollenberg. The network helps show where Lance Wollenberg may publish in the future.

Co-authorship network of co-authors of Lance Wollenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Lance Wollenberg. A scholar is included among the top collaborators of Lance Wollenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance Wollenberg. Lance Wollenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hahn, E. G., et al.. (2025). The Absorption, Distribution, Metabolism, and Excretion of Binimetinib Following a Single Oral Dose of [¹⁴C]Binimetinib 45 mg in Healthy Male Participants. Pharmacology Research & Perspectives. 13(1). e70061–e70061.

Piscitelli, Joseph, Micaela B. Reddy, Lance Wollenberg, et al.. (2024). Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical Pharmacokinetics. 63(4). 483–496. 4 indexed citations

Beck, J. Thaddeus, Dale R. Shepard, Olivier Dumas, et al.. (2024). A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799544 (ARRY-134) as a single agent and in combination with PF-07799933 BRAF dimer inhibitor, in participants 16 years and older with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS3180–TPS3180. 2 indexed citations

Piscitelli, Joseph, Micaela B. Reddy, Lance Wollenberg, et al.. (2024). Evaluation of the effect of modafinil on the pharmacokinetics of encorafenib and binimetinib in patients with BRAF V600-mutant advanced solid tumors. Cancer Chemotherapy and Pharmacology. 94(3). 337–347. 1 indexed citations

Piscitelli, Joseph, Bart Hens, Lance Wollenberg, et al.. (2023). Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An In Vivo–In Vitro–In Silico Approach. Molecular Pharmaceutics. 20(5). 2589–2599. 12 indexed citations

Wollenberg, Lance, E. G. Hahn, Jason H. Williams, & Kevin Litwiler. (2023). A phase I, single‐center, open‐label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [¹⁴C] encorafenib in healthy male subjects. Pharmacology Research & Perspectives. 11(5). e01140–e01140. 5 indexed citations

Hahn, E. G., et al.. (2023). Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations. Clinical and Translational Science. 16(12). 2675–2686. 6 indexed citations

Sullivan, Ryan J., Jeffrey S. Weber, Sapna P. Patel, et al.. (2020). A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with BRAFV600E/K -mutant Solid Tumors. Clinical Cancer Research. 26(19). 5102–5112. 30 indexed citations

Ascierto, Paolo A., Oliver Bechter, Pascal Wolter, et al.. (2017). A phase Ib/II dose-escalation study evaluating triple combination therapy with a BRAF (encorafenib), MEK (binimetinib), and CDK 4/6 (ribociclib) inhibitor in patients (Pts) with BRAF V600-mutant solid tumors and melanoma.. Journal of Clinical Oncology. 35(15_suppl). 9518–9518. 24 indexed citations

10.

Bostick, Christopher D., et al.. (2016). Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism. Drug Metabolism and Disposition. 44(5). 741–749. 11 indexed citations

11.

Wollenberg, Lance, et al.. (2015). An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614). Clinical Pharmacology Advances and Applications. 7. 87–87. 2 indexed citations

12.

Wollenberg, Lance, Matthew J. Powell, Jifeng Chen, et al.. (2013). The Use of Immobilized Cytochrome P4502C9 in PMMA-Based Plug Flow Bioreactors for the Production of Drug Metabolites. Applied Biochemistry and Biotechnology. 172(3). 1293–1306. 15 indexed citations

13.

Lederman, David, Lance Wollenberg, Darcy R. Flora, et al.. (2013). Measurement of Electron Transfer through Cytochrome P450 Protein on Nanopillars and the Effect of Bound Substrates. Journal of the American Chemical Society. 135(10). 3834–3840. 14 indexed citations

14.

Soon, Rachel L., Neang S. Ly, Gauri G. Rao, et al.. (2013). Pharmacodynamic Variability beyond That Explained by MICs. Antimicrobial Agents and Chemotherapy. 57(4). 1730–1735. 11 indexed citations

15.

Wollenberg, Lance, et al.. (2012). Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation. Forensic Science Medicine and Pathology. 9(1). 73–76. 1 indexed citations

16.

Wollenberg, Lance, Yueting Wu, Darcy R. Flora, et al.. (2012). Selective filling of nanowells in nanowell arrays fabricated using polystyrene nanosphere lithography with cytochrome P450 enzymes. Nanotechnology. 23(38). 385101–385101. 9 indexed citations

17.

Wollenberg, Lance, et al.. (2012). Abstract 3709: Synergistic effects of obatoclax (GX15-070) and bortezomib (BTZ) in non-Hodgkin's lymphoma. Cancer Research. 72(8_Supplement). 3709–3709. 1 indexed citations

18.

Berry, Loren, Lance Wollenberg, & Zhiyang Zhao. (2009). Esterase Activities in the Blood, Liver and Intestine of Several Preclinical Species and Humans. Drug Metabolism Letters. 3(2). 70–77. 88 indexed citations

19.

Yang, Mingli, Lance Wollenberg, Xinqi Chen, et al.. (2009). Electrocatalytic Drug Metabolism by CYP2C9 Bonded to A Self-Assembled Monolayer-Modified Electrode. Drug Metabolism and Disposition. 37(4). 892–899. 38 indexed citations

20.

Sun, Hang, Wen Li, Lance Wollenberg, et al.. (2009). Self-Organized Honeycomb Structures of Mn₁₂ Single-Molecule Magnets. The Journal of Physical Chemistry B. 113(44). 14674–14680. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact